| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |